Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00492050 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00492050
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-02
- Primary completion
- 2021-02-28
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.